Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Overview of attention for article published in Lancet Oncology, October 2009

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 22 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 18 additional patents.